http://www.unboundmedicine.com/medline/ebm/research/insulin_glargineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19922879/full_citation/Comparison_of_insulin_detemir_and_insulin_glargine_in_a_basal_bolus_regimen_with_insulin_aspart_as_the_mealtime_insulin_in_patients_with_type_1_diabetes:_A_52_week_multinational_randomized_open_label_parallel_group_Treat_to_Target_noninferiority_trial_Heller S, Koenen C, Bode B 
Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial. [JOURNAL ARTICLE]
Clin Ther 2009 Oct; 31(10):2086-2097.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19921965/full_citation/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_Cooke CE, Lee HY, Tong YP, et al. 
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19919375/full_citation/Comparison_of_daily_insulin_dose_and_other_antidiabetic_medications_usage_for_type_2_diabetes_patients_treated_with_an_analog_basal_insulin_McAdam-Marx C, Yu J, Bouchard J, et al. 
Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19907722/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Sep; 31(7):463-93.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19905891/full_citation/Rationale_design_and_baseline_data_of_the_insulin_glargine__Lantus__versus_insulin_detemir__Levemir__Treat_To_Target__L2T3__study:_A_multinational_randomized_noninferiority_trial_of_basal_insulin_initiation_in_type_2_diabetes_Swinnen SG, Snoek FJ, Dain MP, et al. 
Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes. [Journal Article, Research Support, Non-U.S. Gov't]
Diabetes Technol Ther 2009 Nov; 11(11):739-43.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19905038/full_citation/A_Comparison_of_Costs_among_Patients_with_Type_2_Diabetes_Mellitus_Who_Initiated_Therapy_with_Exenatide_or_Insulin_Glargine_Misurski D, Lage MJ, Fabunmi R, et al. 
A Comparison of Costs among Patients with Type 2 Diabetes Mellitus Who Initiated Therapy with Exenatide or Insulin Glargine. [Journal Article]
Appl Health Econ Health Policy 2009; 7(4):245-54.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19900235/full_citation/Plasma_glucose_and_hypoglycaemia_following_exercise_in_people_with_Type_1_diabetes:_a_comparison_of_three_basal_insulins_Arutchelvam V, Heise T, Dellweg S, et al. 
Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins. [Journal Article, Research Support, Non-U.S. Gov't]
Diabet Med 2009 Oct; 26(10):1027-32.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19896233/full_citation/Direct_costs_associated_with_initiating_NPH_insulin_versus_glargine_in_patients_with_type_2_diabetes:_A_retrospective_database_analysis_Lee LJ, Yu AP, Johnson SJ, et al. 
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis. [JOURNAL ARTICLE]
Diabetes Res Clin Pract 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19895637/full_citation/Mid__and_high_ratio_premix_insulin_analogues:_potential_treatment_options_for_patients_with_type_2_diabetes_in_need_of_greater_postprandial_blood_glucose_control_Christiansen JS, Liebl A, Davidson JA, et al. 
Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control. [JOURNAL ARTICLE]
Diabetes Obes Metab 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19894270/full_citation/Reestablishment_of_the_nasal_permeability_barrier_to_several_peptides_following_exposure_to_the_absorption_enhancer_tetradecyl_beta_D_maltoside_Arnold JJ, Fyrberg MD, Meezan E, et al. 
Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-beta-D-maltoside. [JOURNAL ARTICLE]
J Pharm Sci 2009 Nov 5.
Abstract | Full Citation | Find Related Articles